Work

Supplementary Figures 1 and 2 from A Randomized Phase II Trial of Multiepitope Vaccination with Melanoma Peptides for Cytotoxic T Cells and Helper T Cells for Patients with Metastatic Melanoma (E1602)

Year: 2023

Type: supplementary-materials

Abstract: PDF - 433K, Supplementary Figure 1: Study Schema. Supplementary Figure 2: Association of overall survival and immune response to 6MHP, detail by study arm (Arm C and Arm D.)

DOI: 10.1158/1078-0432.22445556.v1

Authors: Craig L. Slingluff, Sandra Lee, Fengmin Zhao, Kimberly A. Chianese-Bullock, Walter C. Olson, Lisa H. Butterfield, Theresa L. Whiteside, Philip D. Leming, John M. Kirkwood

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362429263

Cites:

Cited by:

Related to: 10